Journal Article Summary
The article investigates the use of dodecyl maltoside, an alkylsaccharide excipient, to improve the delivery of drugs through the nasal route, particularly for treating central nervous system conditions like migraines and epilepsy. Intranasal drug delivery is appealing due to its potential for rapid absorption and onset of action, which is crucial for acute medical situations. However, challenges such as poor absorption and potential damage to nasal tissues can limit its effectiveness. This study highlights the importance of finding safe and effective absorption enhancers to optimize intranasal formulations.
The researchers reviewed existing studies and clinical trials involving dodecyl maltoside, which has been shown to enhance the absorption of various therapeutic agents without causing significant nasal irritation. They found that formulations containing dodecyl maltoside led to improved bioavailability of drugs, allowing larger molecules to be effectively absorbed through the nasal mucosa. Notably, two FDA-approved nasal sprays, sumatriptan for migraines and diazepam for seizure clusters, utilize this excipient, demonstrating its practical application and safety in real-world settings.
Despite the promising results, the article notes some limitations, including the need for further studies to fully understand the long-term effects and safety of dodecyl maltoside in various populations. Patients should be aware that while these formulations can provide rapid relief, they may not be suitable for everyone, and potential side effects, such as mild nasal discomfort, have been reported. It is essential for readers to discuss any concerns or questions about intranasal medications with their healthcare providers to ensure safe and effective treatment options tailored to their individual needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Rabinowicz Adrian L., Carrazana Enrique, Maggio Edward T.. Improvement of Intranasal Drug Delivery with Intravail® Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System. Drugs in R&D 2021. DOI: 10.1007/s40268-021-00360-5. PMID: 34435339. PMCID: PMC8602465.
Featured Pill Pals Product
Sumatriptan 6 MG / 0.5 ML --- Generic For Imitrex --- Auto Injection Syringe --- 2 Syringes Per Box --- Dr. Reddy
Sumatriptan 6 MG / 0.5 ML — Generic For Imitrex — Auto Injection Syringe — 2 Syringes Per Box — Dr. Reddy is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
